Newsroom

Home / Newsroom / Three-Month Interim Safety Data from Phase I Clinical Trial for AlloJoinTM
9Dec

Three-Month Interim Safety Data from Phase I Clinical Trial for AlloJoinTM

Download Full Article as .PDF (Size: 171 kB)

This CBMG article was posted on 9 Dec 2016